Statements (51)
Predicate | Object |
---|---|
gptkbp:instanceOf |
medical condition
|
gptkbp:affects |
kidneys
|
gptkbp:age |
adults
elderly |
gptkbp:alsoKnownAs |
ESRD
end-stage kidney disease |
gptkbp:associatedWith |
gptkb:secondary_hyperparathyroidism
uremia metabolic acidosis hyperphosphatemia |
gptkbp:cause |
gptkb:diabetes_mellitus
hypertension polycystic kidney disease multi-organ failure nephrotic syndrome death if untreated |
gptkbp:characterizedBy |
irreversible loss of kidney function
|
gptkbp:complication |
gptkb:cardiovascular_disease
gptkb:bone gptkb:anemia hyperkalemia fluid overload |
gptkbp:coveredBy |
gptkb:Medicare_(US)
|
gptkbp:definitiveTreatment |
kidney transplantation
|
gptkbp:diagnosedBy |
glomerular filtration rate < 15 mL/min/1.73 m2
|
gptkbp:firstLine |
hemodialysis
peritoneal dialysis |
gptkbp:guidanceSystem |
KDIGO guidelines
KDOQI guidelines |
https://www.w3.org/2000/01/rdf-schema#label |
End-Stage Renal Disease
|
gptkbp:ICD-10_code |
N18.6
|
gptkbp:managedBy |
nephrologist
|
gptkbp:mortalityRate |
high without treatment
|
gptkbp:numberOfStages |
chronic kidney disease
|
gptkbp:occurredIn |
children
|
gptkbp:partOf |
chronic kidney disease
|
gptkbp:prevalence |
millions worldwide
|
gptkbp:prevention |
control of diabetes
control of hypertension |
gptkbp:prognosis |
poor without treatment
|
gptkbp:requires |
renal replacement therapy
|
gptkbp:riskFactor |
long-standing diabetes
long-standing hypertension |
gptkbp:symptom |
nausea
fatigue swelling decreased urine output |
gptkbp:treatment |
dialysis
kidney transplantation |
gptkbp:bfsParent |
gptkb:individuals_with_End-Stage_Renal_Disease_(with_some_exceptions)
|
gptkbp:bfsLayer |
8
|